Endo International (ENDP) Downgraded by Vetr
They presently have a $8.92 price objective on the stock. Vetr 's target price indicates a potential upside of 14.21% from the stock's current price.
from Biotech News
They presently have a $8.92 price objective on the stock. Vetr 's target price indicates a potential upside of 14.21% from the stock's current price.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments